Biomedical Technology Optimization and Dissemination Center (BTOD)
ID: 360446Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/360446
Timeline
    Description

    The National Institutes of Health (NIH) is offering a grant opportunity for the Biomedical Technology Optimization and Dissemination Center (BTOD) program, aimed at optimizing late-stage biomedical technologies that have shown laboratory feasibility. The program's objective is to advance these technologies to a point of widespread use and promote their dissemination within the biomedical research community. This initiative is crucial for enhancing the application of innovative biomedical solutions, thereby contributing to advancements in health research. Interested applicants, including Indian/Native American Tribal Governments, eligible federal agencies, and community-based organizations, can reach out to Dr. Carolina Salvador Morales at carolina.salvadormorales@nih.gov or by phone at 301-480-0779 for further details. The estimated project start date is April 1, 2027, with a synopsis close date projected for May 28, 2026.

    Point(s) of Contact
    Carolina Salvador Morales, Ph.D.
    (301) 480-0779
    carolina.salvadormorales@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Biomedical Technology Optimization and Dissemination Center (BTOD)(RM1-Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the establishment of Biomedical Technology Optimization and Dissemination Centers (BTOD) aimed at supporting late-stage technology optimization and dissemination within the biomedical research community. This initiative encourages applications that focus on optimizing lab-proven technologies and enhancing their usability, with an emphasis on collaborative projects and community engagement strategies to ensure inclusivity and sustainability. Eligible applicants include a wide range of organizations such as educational institutions, nonprofits, and local governments, with a maximum annual budget of $850,000 available for funding, excluding specialized equipment costs. Interested parties should note that the application deadline is January 27, 2026, and can find further details and submission guidelines at the NIH grants website or by contacting NIH Grants Information at grantsinfo@nih.gov.
    Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for the Focused Technology Research and Development (R01 Clinical Trial Not Allowed) grant, aimed at supporting innovative technology projects that advance biomedical research. Eligible applicants include a diverse range of institutions, such as Historically Black Colleges and Universities, Tribal Colleges, and various community-based organizations, with a focus on projects that demonstrate proof-of-concept and the development of working prototypes without integrating clinical trials. This initiative is crucial for fostering technological advancements that enhance understanding of biological processes, with no budget cap and a maximum project duration of five years. Interested applicants can find more information and application guidelines at NIH Grants, with proposals due by January 7, 2028.
    Notice of Intent to Publish a Funding Opportunity Announcement: Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at soliciting applications for research focused on developing biomedical technologies that address health disparities. This initiative seeks to support projects that create effective, affordable, and socially acceptable technologies to improve healthcare access and outcomes for underserved populations. The estimated total program funding for this opportunity is $1,200,000, with an expected two awards to be made, and the application process is anticipated to open in late 2025. Interested applicants can reach out to Nichole Daringer at nichole.daringer@nih.gov or call 301-451-4774 for further information.
    National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "National Centers for Biomedical Imaging and Bioengineering (NCBIB)" aimed at supporting the development and dissemination of new biomedical technologies. This initiative encourages applications from a diverse range of eligible entities, including higher education institutions and nonprofit organizations, to conduct technology research and development projects, collaborative projects, and service projects that address biomedical challenges. The program is designed to foster innovative research and enhance clinical applications, with funding typically ranging from $600,000 to $750,000 per project, and awards may last up to five years, with a total funding cap of fifteen years for any Center. Interested applicants should note that the application process opens on September 25, 2023, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov. For more details, please refer to the full announcement available at https://grants.nih.gov/grants/guide/pa-files/PAR-23-235.html.
    Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities
    National Institutes of Health
    The National Institutes of Health (NIH) is set to announce a funding opportunity titled "Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities" aimed at enhancing research capacity and innovation in bioengineering and biomedical imaging at HBCUs. This initiative aligns with the HBCU PARTNERS Act and seeks to foster collaborations that promote scientific growth and competitiveness in federal research funding. The estimated total program funding is $1,920,000, with four awards anticipated, and interested applicants are encouraged to prepare their proposals ahead of the expected synopsis posting on March 10, 2026, with applications due by June 1, 2026. For further inquiries, potential applicants can contact David Gutekunst, PhD, via email at dave.gutekunst@nih.gov.
    Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)" aimed at supporting innovative research in the development of therapeutic and diagnostic devices for disorders affecting the nervous or neuromuscular systems. This cooperative agreement program encourages investigators to conduct translational activities and clinical feasibility studies, with a focus on advancing medical device technology through collaboration with NIH resources for design, testing, and regulatory support. The initiative is particularly significant as it seeks to accelerate the clinical introduction of medical technologies, ultimately improving patient outcomes while adhering to best practices in research and development. Interested applicants, including various eligible institutions and organizations, must submit their proposals by January 28, 2028, and can find more information at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Toolkits for Dissemination of Genomic Technologies
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Toolkits for Dissemination of Genomic Technologies," aimed at supporting the dissemination of innovative genomic technologies developed in individual labs to the broader scientific community. This initiative seeks to bridge the gap between technology development and widespread adoption by providing integrated toolkits that include custom reagents, hardware, annotated protocols, and training workshops for users. The program is critical for enhancing the validation and maturation of genomic technologies, ultimately facilitating their adoption in scientific research. Interested applicants can apply for grants up to $50,000, with an expected 15 awards to be made, and should contact Ian Nova at ian.nova@nih.gov or 240-987-2885 for further information. Key deadlines include an estimated synopsis post date of March 25, 2026, and a close date of June 24, 2026, with awards anticipated to be made by April 1, 2027.
    Funding Opportunity Announcement - NIBIB Technology Development Networks
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity for the NIBIB Technology Development Networks, aimed at establishing Coordinating Centers that will facilitate collaboration among scientific and engineering communities to address translational challenges in health technology development. These centers will enhance integration across various technology development projects, disseminate program advancements, and manage an Opportunity Funds program to support promising small-scale initiatives. With an estimated total program funding of $1 million and a projected award ceiling of $1 million, this cooperative agreement is expected to yield one award, with applications not currently being solicited. Interested parties are encouraged to prepare for future submissions, with key dates including an estimated synopsis post date of May 1, 2026, and an estimated award date of April 1, 2027. For further inquiries, potential applicants can contact Luisa Russell via email at luisa.russell@nih.gov.
    Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) for the Advancing Bioinformatics, Translational Bioinformatics, and Computational Biology Research initiative, which aims to support innovative research in these fields. This initiative seeks to develop advanced methods and tools that leverage transformative technologies, such as artificial intelligence and machine learning, to enhance the interpretation of complex biological datasets, ultimately improving health outcomes. With an estimated total program funding of $2.5 million and the expectation of awarding approximately 10 grants, interested small businesses are encouraged to prepare their applications, with the anticipated synopsis posting date on October 6, 2025, and a closing date for applications on February 4, 2026. For further inquiries, potential applicants can contact Dr. Catherine Farrell at catherine.farrell@nih.gov or by phone at 301-402-7081.
    Forecast for Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to release a Notice of Funding Opportunity (NOFO) for the Blueprint MedTech Translator program, aimed at supporting small businesses in the development of innovative medical devices for the nervous and neuromuscular systems. This cooperative agreement will provide non-dilutive funding and additional resources to facilitate the translation of groundbreaking technologies from early-stage development to clinical studies, ultimately accelerating patient access to effective medical devices. Interested applicants should note that while applications are not currently being solicited, they are encouraged to begin forming collaborations and developing projects in anticipation of the NOFO, with an estimated synopsis posting date of July 21, 2025, and a closing date of October 20, 2025. For further inquiries, potential applicants can contact Nicholas Langhals, PhD, at Blueprint-MedTech@nih.gov or by phone at 301-435-0090.